milestone pharmaceuticals inc

Mar 06, 2020

Milestone Pharmaceuticals Reports Fourth Quarter and Year-end 2019 Financial Results and Provides Clinical and Corporate Update

Nov 14, 2019

Milestone Pharmaceuticals to Present at Upcoming Investor Conferences

Nov 13, 2019

Milestone Pharmaceuticals Reports Third Quarter 2019 Financial Results and Provides Clinical and Corporate Update

Oct 03, 2019

Milestone Pharmaceuticals Announces First Patient Enrolled in NODE-303 Open-label Safety Study of Etripamil in PSVT

Sep 10, 2019

Milestone Pharmaceuticals Announces Appointment of Amit Hasija as Chief Financial Officer and Executive Vice President of Corporate Development

Aug 29, 2019

Milestone Pharmaceuticals to Participate in Upcoming Investor Conferences

Aug 13, 2019

Milestone Pharmaceuticals Provides Positive Regulatory Updates for Etripamil Pivotal Program in PSVT and Reports Second Quarter 2019 Financial Results

Aug 06, 2019

Milestone Pharmaceuticals to Host Mid-Year Update Conference Call

May 30, 2019

Milestone Pharmaceuticals to Present at the Jefferies 2019 Global Healthcare Conference

May 13, 2019

Milestone Pharmaceuticals Announces Closing of Initial Public Offering

May 08, 2019

Milestone Pharmaceuticals Announces Pricing of Upsized Initial Public Offering